维替泊芬治疗后的改善。 - Suppr

Improvement after verteporfin therapy.

作者信息

Anand Rajiv, Bressler Neil M, Bressler Susan B, Gray Todd E, Harvey Patricia, Haynes Laurie, Koester John M, Manos Kelly S, Miller Joan W, Murphy Sandra, Reaves Al, Sickenberg Michel, Singerman Lawrence J, Strong Andrew, Stur Michael

出版信息

Arch Ophthalmol. 2003 Mar;121(3):415-6. doi: 10.1001/archopht.121.3.415.

DOI:10.1001/archopht.121.3.415

PMID:12617718

Abstract

摘要

相似文献

Improvement after verteporfin therapy.

Arch Ophthalmol. 2003 Mar;121(3):415-6. doi: 10.1001/archopht.121.3.415.

Preserving vision with verteporfin photodynamic therapy.

Hosp Med. 2004 Jan;65(1):39-43. doi: 10.12968/hosp.2004.65.1.2417.

Are the submacular surgery trials still relevant in an era of photodynamic therapy?

Ophthalmology. 2001 Mar;108(3):435-6. doi: 10.1016/s0161-6420(00)00666-7.

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.

Am J Ophthalmol. 2002 Jan;133(1):168-9. doi: 10.1016/s0002-9394(01)01237-5.

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

Arch Ophthalmol. 2005 Apr;123(4):448-57. doi: 10.1001/archopht.123.4.448.

Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration.

Arch Ophthalmol. 1999 Oct;117(10):1400-2. doi: 10.1001/archopht.117.10.1400.

Photodynamic therapy with verteporfin (Visudyne) for macular degeneration.

Med Lett Drugs Ther. 2000 Sep 4;42(1086):81-2.

Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study.

Ophthalmology. 2012 May;119(5):1001-10. doi: 10.1016/j.ophtha.2012.02.003. Epub 2012 Mar 22.

Humphrey perimetry as a predictor of visual improvement after photodynamic therapy.

Jpn J Ophthalmol. 2009 May;53(3):281-2. doi: 10.1007/s10384-008-0644-5. Epub 2009 May 31.

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Am J Ophthalmol. 2003 Sep;136(3):407-18. doi: 10.1016/s0002-9394(03)00223-x.

引用本文的文献

Statins as anti-inflammatory agents: A potential therapeutic role in sight-threatening non-infectious uveitis.

Porto Biomed J. 2017 Mar-Apr;2(2):33-39. doi: 10.1016/j.pbj.2017.01.006. Epub 2017 Mar 1.

Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy.

Doc Ophthalmol. 2007 Sep;115(2):69-76. doi: 10.1007/s10633-007-9056-y. Epub 2007 Aug 2.

Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1085-95. doi: 10.1007/s00417-006-0524-y.

Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation.

Drugs Aging. 2006;23(5):421-45. doi: 10.2165/00002512-200623050-00006.

Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. doi: 10.1007/s00417-005-0021-8. Epub 2005 Jul 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Improvement after verteporfin therapy.

作者信息

出版信息

Arch Ophthalmol. 2003 Mar;121(3):415-6. doi: 10.1001/archopht.121.3.415.

DOI:10.1001/archopht.121.3.415

PMID:12617718

Abstract

摘要

Improvement after verteporfin therapy.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Improvement after verteporfin therapy.

作者信息

出版信息

相似文献

引用本文的文献